非小细胞肺癌术后复发风险预测研究进展
Advances on Postoperative Recurrence Risk Prediction in Non-small Cell Lung Cancer
摘要
肺癌是全球范围内发病率和死亡率最高的恶性肿瘤,其中非小细胞肺癌(non-small cell lung cancer,NSCLC)约占85%.根治性手术切除是可切除NSCLC患者获得长期生存的主要手段,但仍有部分患者出现术后复发,影响预后转归.因此,精准预测术后复发风险、筛选高危人群并制定个体化辅助治疗及随访策略,对改善患者预后具有重要意义.近年来,随着人工智能与液体活检等技术的快速发展,NSCLC术后复发风险预测正逐步迈向精细化与个体化.本文综述传统模型、人工智能模型及液体活检技术在NSCLC术后复发预测中的应用现状,分析其优势与局限,并对未来研究趋势进行展望.
Lung cancer remains the malignant tumor with the highest incidence and mortality rates worldwide,with non-small cell lung cancer(NSCLC)accounting for approximately 85%of cases.Radical surgical resection serves as the primary curative modality for patients with resectable NSCLC;however,postoperative recurrence persists in a subset of pa-tients,thereby compromising long-term survival outcomes.Consequently,the precise prediction of postoperative recurrence risk,identification of high-risk populations,and formulation of individualized adjuvant therapy and surveillance strategies are of paramount importance for improving patient prognosis.In recent years,fueled by the rapid evolution of artificial intelligence(AI)and liquid biopsy technologies,the prediction of postoperative recurrence in NSCLC has progressively transitioned to-ward greater precision and personalization.This review summarizes the current applications of traditional predictive models,AI-based models,and liquid biopsy techniques in forecasting NSCLC recurrence following surgery,evaluating their respective strengths and limitations.Furthermore,it provides insights into future research trajectories.
年,卷(期):
2026, 29(8)
机标分类号:
R734.2
R273.42
R605.97
在线出版日期:
2026年10月29日